It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NVST’s FA Score shows that 0 FA rating(s) are green whileSTAA’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NVST’s TA Score shows that 4 TA indicator(s) are bullish while STAA’s TA Score has 3 bullish TA indicator(s).
NVST (@Pharmaceuticals: Other) experienced а +1.01% price change this week, while STAA (@Pharmaceuticals: Other) price change was -1.79% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.31%. For the same industry, the average monthly price growth was +2.43%, and the average quarterly price growth was +6.56%.
NVST is expected to report earnings on Oct 29, 2025.
STAA is expected to report earnings on Oct 29, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
NVST | STAA | NVST / STAA | |
Capitalization | 3.51B | 1.35B | 260% |
EBITDA | 303M | -73.24M | -414% |
Gain YTD | 8.761 | 11.836 | 74% |
P/E Ratio | 65.56 | 49.73 | 132% |
Revenue | 2.55B | 224M | 1,140% |
Total Cash | 1.11B | 190M | 585% |
Total Debt | 1.6B | 40.5M | 3,941% |
NVST | STAA | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 73 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 91 | 96 | |
PRICE GROWTH RATING 1..100 | 48 | 42 | |
P/E GROWTH RATING 1..100 | 46 | 87 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NVST's Valuation (73) in the null industry is in the same range as STAA (86) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.
NVST's Profit vs Risk Rating (100) in the null industry is in the same range as STAA (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.
NVST's SMR Rating (91) in the null industry is in the same range as STAA (96) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.
STAA's Price Growth Rating (42) in the Medical Specialties industry is in the same range as NVST (48) in the null industry. This means that STAA’s stock grew similarly to NVST’s over the last 12 months.
NVST's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for STAA (87) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than STAA’s over the last 12 months.
NVST | STAA | |
---|---|---|
RSI ODDS (%) | N/A | 2 days ago79% |
Stochastic ODDS (%) | 2 days ago73% | 2 days ago75% |
Momentum ODDS (%) | 2 days ago61% | 2 days ago80% |
MACD ODDS (%) | 2 days ago74% | 2 days ago90% |
TrendWeek ODDS (%) | 2 days ago68% | 2 days ago83% |
TrendMonth ODDS (%) | 2 days ago70% | 2 days ago84% |
Advances ODDS (%) | 14 days ago66% | 14 days ago74% |
Declines ODDS (%) | 2 days ago69% | 2 days ago86% |
BollingerBands ODDS (%) | 2 days ago57% | 2 days ago75% |
Aroon ODDS (%) | 2 days ago71% | 2 days ago71% |
A.I.dvisor indicates that over the last year, NVST has been loosely correlated with BIO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then BIO could also see price increases.
Ticker / NAME | Correlation To NVST | 1D Price Change % | ||
---|---|---|---|---|
NVST | 100% | -0.57% | ||
BIO - NVST | 57% Loosely correlated | -0.70% | ||
A - NVST | 55% Loosely correlated | -0.37% | ||
XRAY - NVST | 54% Loosely correlated | -1.40% | ||
ALGN - NVST | 54% Loosely correlated | -1.81% | ||
AZTA - NVST | 53% Loosely correlated | -0.42% | ||
More |
A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.
Ticker / NAME | Correlation To STAA | 1D Price Change % | ||
---|---|---|---|---|
STAA | 100% | -0.24% | ||
XRAY - STAA | 53% Loosely correlated | -1.40% | ||
WST - STAA | 44% Loosely correlated | -0.66% | ||
OFIX - STAA | 38% Loosely correlated | +0.67% | ||
CSTL - STAA | 38% Loosely correlated | +0.32% | ||
IQV - STAA | 37% Loosely correlated | -0.06% | ||
More |